An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients-Reference-Cited by-同舟云学术

An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients

Published:2010-02 Issue:2 Volume:57 Page:238-245
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bedognetti Davide,Rubagotti Alessandra,Conti Giario,Francesca Francesco,De Cobelli Ottavio,Canclini Luca,Gallucci Michele,Aragona Francesco,Di Tonno Pasquale,Cortellini Pietro,Martorana Giuseppe,Lapini Alberto,Boccardo Francesco

Publisher

Elsevier BV

Subject

Urology

Reference25 articles.

1. Antiandrogens in the treatment of prostate cancer;Wirth;Eur Urol,2007

2. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of follow-up;Iversen;J Urol,2000

3. A randomised comparison of ‘Casodex’® (bicalutamide) 150mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer;Tyrrell;Eur Urol,1998

4. Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study;Boccardo;J Clin Oncol,1999

5. Adjuvant hormonal treatment—the bicalutamide early prostate cancer program;Wirth;Front Radiat Ther Oncol,2008

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In den allermeisten Fällen selbstlimitierend;Pädiatrie;2022-09

2. Gynécomastie en pratique clinique pour les urologues;Urologie in der Praxis;2021-10-20

3. Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer;Strahlentherapie und Onkologie;2020-03-12

4. Managing Male Mammary Maladies;European Journal of Breast Health;2018-01-02

5. A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer;Clinical Genitourinary Cancer;2017-04